Dey, L.P. v. Sepracor, Inc.
District Court, D. Delaware
1Opinion of the Court
MEMORANDUM OPINION
FARNAN, District Judge.
Presently before the Court is Defendant Sepracor’s Motion To Dismiss for lack of subject matter jurisdiction. (D.I.8.) For the reasons discussed, the Motion will be denied.
I. PROCEDURAL BACKGROUND
On June 20, 2008 Plaintiffs Dey L.P. and Dey, Inc. (collectively, “Dey”) brought this action, seeking a declaratory judgment that their proposed generic levalbuterol hydrochloride inhalation products, if marketed, would not infringe U.S. Patent No. 6,341,289 (“the '289 patent”), which is owned by Defendant Sepracor. (D.I. 1.) On August 13, 2008, Sepracor moved…
2Cases cited7 opinions
- MedImmune, Inc. v. Genentech, Inc.Supreme Court of the United States · 2007
- Teva Pharmaceuticals Usa, Inc. v. Novartis Pharmaceuticals Corporation, Novartis Pharma Ag and Novartis International Pharmaceutical Ltd.Court of Appeals for the Federal Circuit · 2007
- Caraco Pharmaceutical Laboratories, Ltd. v. Forest Laboratories, Inc.Court of Appeals for the Federal Circuit · 2008
- EMC Corp. v. Norand Corp.Court of Appeals for the Federal Circuit · 1996
- Shell Oil Company v. Amoco CorporationCourt of Appeals for the Federal Circuit · 1992
2 more not listed; retrieve them via the Exa API.
3Cited by4 opinions
- Alza Corp. v. ANDRX PHARMACEUTICALS, LLCDistrict Court, D. Delaware · 2009
- Pfizer Inc. v. Apotex Inc.District Court, N.D. Illinois · 2010
- Dey Pharma, LP v. SUNOVION PHARMACEUTICALS INC.Court of Appeals for the Federal Circuit · 2012
- Team Angry Filmworks, Inc. v. GeerDistrict Court, W.D. Pennsylvania · 2016